Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...

Share on Pinterest Scientists have found a link between certain eye conditions and GLP-1 medications. BONNINSTUDIO/Stocksy Past studies have found a potential link between semaglutide and the eye ...

Are you a print subscriber? Activate your account. By Gillian Follett - 40 min 51 sec ago By Rob Mayhew - 1 hour 41 min ago 3 hours 15 min ago By Ewan Larkin - 4 hours 52 min ago By Adrianne ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In this article, we are going to take a look at where Global Partners LP (NYSE:GLP) stands against other oil & gas stocks that are skyrocketing so far in 2025. The oil & gas sector has ...

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on whether the medications caused the eye ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

Alliance Global Partners raised the firm’s price target on Rigetti Computing (RGTI) to $15 from $5.50 and keeps a Buy rating on the shares.

Of course, there are new factors at play now, too, like patients on Ozempic whose doctors encourage them to eat diets high in protein to prevent muscle loss, which can be a side effect of GLP-1 ...

PAA Plains All American Pipeline, L.P.

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad BMS extends its cost-cutting drive by another $2bn RFK Jr odds on for HHS role after Finance Committee vote ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...